BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 38481255)

  • 1. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review.
    Kut C; Kleinberg L
    Chin Clin Oncol; 2023 Feb; 12(1):4. PubMed ID: 36922353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
    Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
    Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy.
    Mapelli R; Julita C; Bianchi SP; Gallina N; Lucchini R; Midulla M; Puci F; Saddi J; Trivellato S; Panizza D; De Ponti E; Arcangeli S
    Strahlenther Onkol; 2022 May; 198(5):448-457. PubMed ID: 34617129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.
    Mendez JS; Govindan A; Leong J; Gao F; Huang J; Campian JL
    J Neurooncol; 2016 Apr; 127(2):329-35. PubMed ID: 26725885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era.
    Byun HK; Kim N; Yoon HI; Kang SG; Kim SH; Cho J; Baek JG; Chang JH; Suh CO
    Radiat Oncol; 2019 Mar; 14(1):51. PubMed ID: 30917849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
    Reardon DA; Brandes AA; Omuro A; Mulholland P; Lim M; Wick A; Baehring J; Ahluwalia MS; Roth P; Bähr O; Phuphanich S; Sepulveda JM; De Souza P; Sahebjam S; Carleton M; Tatsuoka K; Taitt C; Zwirtes R; Sampson J; Weller M
    JAMA Oncol; 2020 Jul; 6(7):1003-1010. PubMed ID: 32437507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma.
    Ahn S; Park JS; Jang J; Ahn KJ; Hong YK; Yang SH; Jeun SS
    J Clin Neurosci; 2020 Jan; 71():21-25. PubMed ID: 31843432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy.
    Ye LL; Fan XW; Hu CS; He XY; Wang XS; Shen CY; Xu TT; Ying HM
    Cancer Med; 2019 Jun; 8(6):2759-2768. PubMed ID: 30983159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma.
    Kim WJ; Dho YS; Ock CY; Kim JW; Choi SH; Lee ST; Kim IH; Kim TM; Park CK
    J Neurooncol; 2019 Jun; 143(2):321-328. PubMed ID: 30982199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.
    Chongsathidkiet P; Jackson C; Koyama S; Loebel F; Cui X; Farber SH; Woroniecka K; Elsamadicy AA; Dechant CA; Kemeny HR; Sanchez-Perez L; Cheema TA; Souders NC; Herndon JE; Coumans JV; Everitt JI; Nahed BV; Sampson JH; Gunn MD; Martuza RL; Dranoff G; Curry WT; Fecci PE
    Nat Med; 2018 Sep; 24(9):1459-1468. PubMed ID: 30104766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
    Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors.
    Venkatesulu BP; Mallick S; Lin SH; Krishnan S
    Crit Rev Oncol Hematol; 2018 Mar; 123():42-51. PubMed ID: 29482778
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.